ScreenFlow: Strategy for Finding Cases of Moderate-to-Severe COPD

NCT02753556 | Completed

• 1 other identifier: HHSN268201400046C
• Study Type: observational
• Target: 399
• Locations: 0 countries
• Sites: N/A

Brief Summary

ScreenFlow is a chronic obstructive pulmonary disease (COPD) screening tool currently being studied and iteratively developed that incorporates a questionnaire administered on a tablet and data from a digital peak flow meter to calculate a risk score to identify the risk of developing moderate-to-severe COPD for the participant. The purpose of this study is to assess the usability of ScreenFlow deployed as a free-standing kiosk and observe where users encounter trouble navigating the system. The kiosk will be situated in a public area of a hospital where passersby can approach and fill out a ScreenFlow survey if they meet the eligibility criteria. A subset of participants will be asked to participate in a follow-up questionnaire about their experience using the system and about any follow-up action they may have taken caused by their results from the ScreenFlow screening.

Conditions

Pulmonary Disease, Chronic Obstructive

Keywords

Chronic Obstructive Pulmonary Disease; COPD; ScreenFlow; Screening; Lung Disease; Mobile Health; Peak Flow Meter; Usability

Outcome Measures

Primary Outcomes (1)

• Proportion of positive ScreenFlow screens among participants that use system

  Out of the entirety of screening results for all participants that use the ScreenFlow system during the study, calculation of the proportion of "positive" screens

  Six weeks

Secondary Outcomes (3)

• Qualitative feedback on the usability of the ScreenFlow system

  Six weeks

• Click-based usability testing of the ScreenFlow interface

  Six weeks

• Proportion of adults exposed to the ScreenFlow system that actually use it

  Six weeks

Eligibility Criteria

• Age: 40 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Participants from which possible participants will self-select is of people that pass through the pharmacy entrances at the Boston Medical Center.

You may qualify if:

• years of age or older, able to use tablet

You may not qualify if:

• History of pneumothorax or collapsed lung, surgery in the past 6 months (oral, eye, chest, abdomen), non-English speaking, signs and symptoms of an active upper respiratory tract infection, legally blind and/or deaf

Sponsors & Collaborators

• Dimagi Inc.: lead
• Boston Medical Center: collaborator

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Lung Diseases

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: INDUSTRY
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 25, 2016
• First Posted: April 28, 2016
• Study Start: September 1, 2015
• Primary Completion: June 1, 2016
• Study Completion: June 1, 2016
• Last Updated: February 1, 2018

Record last verified: 2018-01

Data Sharing

• IPD Sharing: Will not share